SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Valuation
CRSP 56.98+1.1%Nov 5 3:59 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: XenaLives who wrote (3653)5/1/2001 10:35:08 PM
From: Biomaven  Read Replies (2) of 52153
 
Paula,

I've never cared much for cancer vaccine programs, particularly those that have to be individualized to the patient. Getting regulatory blessing for the manufacturing process is always going to be very hard.

There are also going to be a bunch of potential vaccine competitors down the line with effective comparisons between them difficult. So I think the marketing is likely to be tricky as well.

There is also lots of turmoil at the company between the management changes and the FDA problems.

I have no idea at all if the low price of the stock compensates for these issues. <g>

Peter
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News